Applied Pb Ratio from 2010 to 2024

APLT Stock  USD 8.57  1.64  16.06%   
Applied Therapeutics PB Ratio yearly trend continues to be comparatively stable with very little volatility. PB Ratio is likely to outpace its year average in 2024. From the period from 2010 to 2024, Applied Therapeutics PB Ratio quarterly data regression had r-value of  0.59 and coefficient of variation of (116.65). View All Fundamentals
 
PB Ratio  
First Reported
2010-12-31
Previous Quarter
(16.46)
Current Value
(15.64)
Quarterly Volatility
13.47177566
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Applied Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 1.4 M, Interest Income of 1.1 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 22.59, Dividend Yield of 0.0 or Days Sales Outstanding of 8.33. Applied financial statements analysis is a perfect complement when working with Applied Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Applied Therapeutics Correlation against competitors.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Latest Applied Therapeutics' Pb Ratio Growth Pattern

Below is the plot of the Pb Ratio of Applied Therapeutics over the last few years. It is Applied Therapeutics' PB Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Applied Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Pb Ratio10 Years Trend
Slightly volatile
   Pb Ratio   
       Timeline  

Applied Pb Ratio Regression Statistics

Arithmetic Mean(11.55)
Geometric Mean13.72
Coefficient Of Variation(116.65)
Mean Deviation12.08
Median(21.75)
Standard Deviation13.47
Sample Variance181.49
Range32.4803
R-Value0.59
Mean Square Error128.05
R-Squared0.34
Significance0.02
Slope1.77
Total Sum of Squares2,541

Applied Pb Ratio History

2024 -15.64
2023 -16.46
2022 7.08
2021 3.66
2020 5.9
2019 10.73
2018 5.45

About Applied Therapeutics Financial Statements

Applied Therapeutics shareholders use historical fundamental indicators, such as Pb Ratio, to determine how well the company is positioned to perform in the future. Although Applied Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Applied Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Applied Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
PB Ratio(16.46)(15.64)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.